Filters
Treatment with secukinumab helps reduce symptoms and disease activity in Chinese children with enthesitis-related arthritis, as shown in a retrospective study.
A novel active driving system for paediatric ventricular assist devices exhibits safety and reliability in children with heart failure, with no major malfunctions, according to a study.
Satralizumab reduces the risk of relapse by 68 percent in adults and adolescents with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), as shown in the phase III METEOROID study presented at AAN 2026.
Vaccination with BNT162b2 against SARS-CoV-2 infections has helped reduce accident and emergency (A&E) attendance and hospitalization among adolescents and children, reports a study.
Antibiotic resistance genes (ARGs)—DNA segments that enable bacterial survival in the presence of antibiotics— can be detected in newborns’ meconium shortly after birth, as shown in a study presented at ESCMID Global 2026.
Children who have been maltreated require care that routine surveillance practice do not fully meet, according to a Singapore study. Moreover, these kids are at risk of shirking their hospital appointments.
An observational study shows an association between adjunctive clindamycin and reduced odds of mortality in children with invasive Group A streptococcal (iGAS) infections.
A short-term intervention combining sleep scheduling and use of bright-light glasses in the morning and blue light–blocking glasses in the evening can correct the circadian timing and extend weeknight sleep duration in adolescents, as shown in a study.
A study presented at ESPID 2026 demonstrates an association between respiratory syncytial virus (RSV) infection and an increased risk of childhood asthma.
New drug applications approved by US FDA as of 1-15 May 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.